CollPlant Biotechnologies (CLGN) Net Income (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted Net Income of -$3.1 million for Q1 2026, down 115.76% on a QoQ basis from $19.8 million in Q4 2025, and down 89.02% year-over-year from -$28.4 million in Q1 2025.
CollPlant Biotechnologies (CLGN) Net Income (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies' Net Income history runs 10 years deep, the most recent figure standing at -$3.1 million for Q1 2026.
- Quarterly Net Income fell 89.02% year-over-year to -$3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (up 169.88% YoY) and the FY2025 annual result came in at $11.5 million, up 169.17% from the prior year.
- Net Income was -$3.1 million for Q1 2026 at CollPlant Biotechnologies, down from $19.8 million in the prior quarter.
- Across five years, Net Income topped out at $19.8 million in Q4 2025 and bottomed at -$4.7 million in Q4 2023.
- A 5-year average of -$397882.4 and a median of -$3.3 million in 2025 frame the typical range for Net Income.
- Annual changes were most pronounced in 2022 — Net Income jumped 1756.97% — and 2023, when it plunged 1094249900.0%.
- CollPlant Biotechnologies' Net Income stood at $4.4 million in 2022, then sank by 206.54% to -$4.7 million in 2023, then climbed by 17.3% to -$3.9 million in 2024, then jumped by 609.82% to $19.8 million in 2025, then sank by 115.76% to -$3.1 million in 2026.
- Business Quant data shows CLGN's Net Income at -$3.1 million in Q1 2026, $19.8 million in Q4 2025, and -$3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | -3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -3.12 Mn |
| Dec 31, 2025 | 19.77 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Jun 30, 2025 | -3.35 Mn |
| Mar 30, 2025 | -1.65 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | -4.33 Mn |
| Jun 30, 2024 | -4.21 Mn |
| Mar 31, 2024 | -4.20 Mn |
| Dec 31, 2023 | -4.69 Mn |
| Sep 30, 2023 | -4.38 Mn |
| Jun 30, 2023 | -1.67 Mn |
| Mar 31, 2023 | 3.72 Mn |
| Dec 31, 2022 | 4.40 Mn |
| Sep 30, 2022 | -0.40 |
| Jun 30, 2022 | 8.14 Mn |
| Mar 31, 2022 | -3.86 Mn |
| Dec 31, 2021 | 236,999.58 |
| Sep 30, 2021 | -0.29 |
| Jun 30, 2021 | 7.09 Mn |